Open AccessNetwork meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis
Author(s) -
Conor Hanrahan,
Todd A. Lee
Publication year - 2021
Publication title -
american journal of health-system pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 96
eISSN - 1535-2900
pISSN - 1079-2082
DOI - 10.1093/ajhp/zxab042
Subject(s) - infliximab , medicine , biosimilar , rheumatoid arthritis , meta analysis , adverse effect , randomized controlled trial , odds ratio , rheumatology , tumor necrosis factor alpha
This article assesses the relative efficacy and safety of infliximab biosimilars in treatment of patients with rheumatoid arthritis (RA).